Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accelerated iTBS for PTSD and Depression

NCT: NCT07682207 · NOT_YET_RECRUITING

NCT IDNCT07682207
StatusNOT_YET_RECRUITING
Start Date2026-07
Completion2027-09
SponsorLawson Research Institute of St. Joseph's (OTHER)
First posted
Last updated

Brief Summary

The goal of this pilot clinical trial is to learn if a faster brain stimulation schedule is practical, safe, tolerable, and acceptable. This study looks at accelerated intermittent theta burst stimulation, or accelerated iTBS. This is a non-invasive type of magnetic brain stimulation. This study is for adults with post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). The main questions this study aims to answer are: 1. Can participants complete six short brain stimulation sessions per day for five days? 2. Is this treatment schedule safe and tolerable for participants? 3. What changes occur in depression symptoms, PTSD symptoms, anxiety, quality of life, and brain activity over time? Participants will: 1. Complete health screening and baseline assessments. 2. Receive six short sessions of magnetic brain stimulation per day for five days. 3. Have their brain activity measured using an EEG recording. 4. Return for a post-treatment assessment at Week 2 and follow-up visits at Week 5 and Week 12.

Frequently Asked Questions

What is Accelerated iTBS for PTSD and Depression?

Accelerated iTBS for PTSD and Depression is a clinical trial registered under NCT07682207. Current status: NOT_YET_RECRUITING.

What is the status of NCT07682207?

The current status of NCT07682207 (Accelerated iTBS for PTSD and Depression) is: NOT_YET_RECRUITING.

When did Accelerated iTBS for PTSD and Depression start?

Accelerated iTBS for PTSD and Depression started on 2026-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.